Walgreens Boots Alliance, Inc. Website

Walgreens Boots Alliance, Inc.

NasdaqGS-WBA

Basic

  • Market Cap

    $9,936.3M

  • EV

    $44.68B

  • Shares Out

    863.28M

  • Revenue

    $145.53B

  • Employees

    268,500

Margins

  • Gross

    18.38%

  • EBITDA

    2.72%

  • Operating

    1.29%

  • Pre-Tax

    -9.32%

  • Net

    -3.99%

  • FCF

    -0.61%

Returns (5Yr Avg)

  • ROA

    0.99%

  • ROTA

    3.55%

  • ROE

    2.81%

  • ROCE

    5.4%

  • ROIC

    3.45%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • P/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    $13.62

  • P/E

  • PEG

  • EV/Sales

  • EV/EBITDA

  • P/FCF

Financial Health

  • Cash

    $711M

  • Net Debt

    $32.95B

  • Debt/Equity

    2.18

  • EBIT/Interest

    3.54

Growth (CAGR)

  • Rev 3Yr

    4.2%

  • Rev 5Yr

    1.31%

  • Rev 10Yr

    6.81%

  • Dil EPS 3Yr

    36.65%

  • Dil EPS 5Yr

    5.69%

  • Dil EPS 10Yr

    8.76%

  • Rev Fwd 2Yr

    3.1%

  • EBITDA Fwd 2Yr

    -8.85%

  • EPS Fwd 2Yr

    -25.25%

  • EPS LT Growth Est

    -14.7%

Dividends

  • Yield

  • Payout

    -21.68%

  • DPS

    $1.46

  • DPS Growth 3Yr

    -7.92%

  • DPS Growth 5Yr

    -3.67%

  • DPS Growth 10Yr

    1.48%

  • DPS Growth Fwd 2Yr

    1.51%

Select a metric from the list below to chart it

Aug '14

Aug '15

Aug '16

Aug '17

Aug '18

Aug '19

Aug '20

Aug '21

Aug '22

Aug '23

LTM

Aug '24 (E)

Aug '25 (E)

Aug '26 (E)

Total Revenues

120,074

121,982

132,509

132,703

139,081

145,533

Total Revenues % Chg.

-8.7%

1.6%

8.6%

0.1%

4.8%

6.9%

Cost of Goods Sold, Total

91,915

95,905

104,442

104,437

112,009

118,787

Gross Profit

28,159

26,077

28,067

28,266

27,072

26,746

Selling General & Admin Expenses, Total

23,183

22,836

23,798

24,627

24,860

24,863

Other Operating Expenses, Total

23,183

22,836

23,798

24,627

24,860

24,863

Operating Income

4,976

3,241

4,269

3,639

2,212

1,883

Interest Expense, Total

-676

-584

-916

-420

-606

-532

Interest And Investment Income

26

425

24

26

26

Net Interest Expenses

-650

-584

-491

-396

-580

-506

Income (Loss) On Equity Invest.

172

372

-512

468

285

259

Currency Exchange Gains (Loss)

121

11

-8

523

-273

-51

Other Non Operating Income (Expenses)

38

-37

83

-602

275

-713

EBT, Excl. Unusual Items

4,657

3,003

3,341

3,632

1,919

872

Restructuring Charges

-352

-125

-417

-763

-1,181

-1,807

Merger & Related Restructuring Charges

-315

-54

-223

-323

-323

Impairment of Goodwill

-1,700

-12,369

Gain (Loss) On Sale Of Investments

-70

290

2,945

1,964

1,212

Gain (Loss) On Sale Of Assets

-557

Asset Writedown

-80

-316

-49

-783

-299

Legal Settlements

-31

-75

-768

-7,466

-593

Other Unusual Items

173

-414

-4

EBT, Incl. Unusual Items

4,367

477

2,622

4,036

-5,386

-13,565

Income Tax Expense

577

339

667

-30

-1,858

-987

Earnings From Continuing Operations

3,790

138

1,955

4,066

-3,528

-12,578

Earnings Of Discontinued Operations

166

277

548

Minority Interest

26

41

39

271

448

6,767

Net Income

3,982

456

2,542

4,337

-3,080

-5,811

Net Income to Common Incl Extra Items

3,982

456

2,542

4,337

-3,080

-5,811

Net Income to Common Excl. Extra Items

3,816

179

1,994

4,337

-3,080

-5,811

Total Shares Outstanding

895.4

865.6

865.4

864.6

863.7

863.3

Weighted Avg. Shares Outstanding

921.5

879.4

864.8

864.4

863.2

863.1

Weighted Avg. Shares Outstanding Dil

923.5

880.3

866.4

865.9

863.2

863.1

EPS

4.3

0.5

2.9

5

-3.6

-6.7

EPS Diluted

4.3

0.5

2.9

5

-3.6

-6.7

EBITDA

6,754

4,868

5,958

5,322

4,098

3,954

Effective Tax Rate

13.2%

71.1%

25.4%

-0.7%

34.5%

7.3%